Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial

Letìzia Spinelli; Antonio Pisani; Giuseppe Giugliano; Bruno Trimarco; Eleonora Riccio; Bianca Visciano; Giuseppe Remuzzi; Piero Ruggenenti

doi:10.1016/j.ijcard.2018.10.063

Related publications

Article2015

SuO039LONG TERM EFFECTS OF OCTREOTIDE TREATMENT IN ADPKD PATIENTS WITH POLYCYSTIC LIVER DISEASE (A SUB-GROUP ANALYSIS OF THE ALADIN TRIAL)

Antonio Pisani, Piero Ruggenenti, Giuseppe Remuzzi, Eleonora Riccio, Massimo Sabbatini

Article2019

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

Norberto Perico, Piero Ruggenenti, Annalisa Perna, Anna Caroli, Matias Trillini, Sandro Sironi, Antonio Pisani, Eleonora Riccio, Massimo Imbriaco, Mauro Dugo, Giovanni Morana, Antonio Granata, Michele Figuera, Flavio Gaspari, Fabiola Carrara, Nadia Rubis, Alessandro Villa, Sara Gamba, Silvia Prandini, Monica Cortinovis, Andrea Remuzzi, Giuseppe Remuzzi

Article2020

Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial

Giovanni Cioffi, Carlo Giorda, Donata Lucci, Elisa Nada, Federica Ognibeni, Costantino Mancusi, Roberto Latini, Aldo Maggioni

Article2010

Cross-Sectional Relations of Lipid Concentrations to Left Ventricular Structural Attributes

Raghava S. Velagaleti, Michael J. Pencina, Ramachandran S. Vasan, Emelia Benjamin, Joseph M. Massaro, Karol M. Pencina, Daniel Levy

Article2005

Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions

Ravi Dhingra, Byung Ho Nam, Emelia Benjamin, Thomas J. Wang, Martin G. Larson, Ralph B. D’Agostino, Daniel Levy, Ramachandran S. Vasan